Connection

Marc Chimowitz to Male

Back to Details
This is a "connection" page, showing publications Marc Chimowitz has written about Male.
Marc Chimowitz
Connection Strength
0.657
Male
  1. Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105254.
    View in: PubMed
    Score: 0.038
  2. Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104713.
    View in: PubMed
    Score: 0.037
  3. Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial. Neurology. 2015 Dec 15; 85(24):2090-7.
    View in: PubMed
    Score: 0.027
  4. Yet again no benefit of stenting over medical therapy. Lancet Neurol. 2015 Jun; 14(6):565-6.
    View in: PubMed
    Score: 0.026
  5. Endovascular therapy for atherosclerotic intracranial arterial stenosis: back to the drawing board. JAMA. 2015 Mar 24-31; 313(12):1219-20.
    View in: PubMed
    Score: 0.026
  6. Is calcification of intracranial arteries important and how? JAMA Neurol. 2014 Apr; 71(4):401-2.
    View in: PubMed
    Score: 0.025
  7. Game changer for endovascular treatment of acute ischemic stroke? J Neurointerv Surg. 2014 May; 6(4):252-3.
    View in: PubMed
    Score: 0.024
  8. In reply: Is there a contribution of anesthesia to the outcome of the SAMMPRIS trial? Neurosurgery. 2014 Feb; 74(2):E235-6.
    View in: PubMed
    Score: 0.024
  9. The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep. 2013 Dec; 15(12):422.
    View in: PubMed
    Score: 0.024
  10. Endovascular treatment for acute ischemic stroke--still unproven. N Engl J Med. 2013 Mar 07; 368(10):952-5.
    View in: PubMed
    Score: 0.023
  11. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 Sep 15; 365(11):993-1003.
    View in: PubMed
    Score: 0.021
  12. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke. 2009 Mar; 40(3):719-25.
    View in: PubMed
    Score: 0.017
  13. Re: Turk et al and the "how do we spin wingspan?" commentary. AJNR Am J Neuroradiol. 2008 Sep; 29(8):e69; author reply e70.
    View in: PubMed
    Score: 0.016
  14. A clinical example of the "limping brain" syndrome: a case report. AJNR Am J Neuroradiol. 2005 Jun-Jul; 26(6):1521-4.
    View in: PubMed
    Score: 0.013
  15. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005 Mar 31; 352(13):1305-16.
    View in: PubMed
    Score: 0.013
  16. Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study. J Stroke Cerebrovasc Dis. 2021 Feb; 30(2):105504.
    View in: PubMed
    Score: 0.010
  17. Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial. Stroke. 2020 10; 51(10):2960-2971.
    View in: PubMed
    Score: 0.010
  18. Mechanisms of early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD): Rationale and design. J Stroke Cerebrovasc Dis. 2020 Oct; 29(10):105051.
    View in: PubMed
    Score: 0.009
  19. New ischemic lesions on brain magnetic resonance imaging in patients with blunt traumatic cerebrovascular injury. J Trauma Acute Care Surg. 2020 06; 88(6):796-802.
    View in: PubMed
    Score: 0.009
  20. Type and Duration of Exercise in the SAMMPRIS Trial. Neurologist. 2019 Jan; 24(1):10-12.
    View in: PubMed
    Score: 0.009
  21. Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2018 Mar; 27(3):801-805.
    View in: PubMed
    Score: 0.008
  22. Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials. Int J Stroke. 2017 10; 12(7):770-778.
    View in: PubMed
    Score: 0.008
  23. Frequency and severity of asymptomatic coronary disease in patients with different causes of stroke. Stroke. 1997 May; 28(5):941-5.
    View in: PubMed
    Score: 0.008
  24. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Stroke. 2017 06; 48(6):1501-1506.
    View in: PubMed
    Score: 0.008
  25. Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis. J Stroke Cerebrovasc Dis. 2017 Mar; 26(3):488-493.
    View in: PubMed
    Score: 0.007
  26. Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2017 Jan; 26(1):108-115.
    View in: PubMed
    Score: 0.007
  27. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. JAMA Neurol. 2016 Mar; 73(3):308-15.
    View in: PubMed
    Score: 0.007
  28. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. JAMA Neurol. 2016 Jan; 73(1):36-42.
    View in: PubMed
    Score: 0.007
  29. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Stroke. 2015 Nov; 46(11):3282-4.
    View in: PubMed
    Score: 0.007
  30. Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID? Stroke. 2015 Sep; 46(9):2562-7.
    View in: PubMed
    Score: 0.007
  31. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology. 1995 Aug; 45(8):1488-93.
    View in: PubMed
    Score: 0.007
  32. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015 Mar; 46(3):775-9.
    View in: PubMed
    Score: 0.006
  33. Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease. Veterans Affairs Cooperative Study Group 167. Stroke. 1994 Apr; 25(4):759-65.
    View in: PubMed
    Score: 0.006
  34. Death associated with asymptomatic carotid artery stenosis: long-term clinical evaluation. VA Cooperative Study 167 Group. J Vasc Surg. 1993 Dec; 18(6):1002-9; discussion 1009-11.
    View in: PubMed
    Score: 0.006
  35. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
    View in: PubMed
    Score: 0.006
  36. Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke. 1993 Jul; 24(7):1015-9.
    View in: PubMed
    Score: 0.006
  37. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013 May; 72(5):777-95; discussion 795.
    View in: PubMed
    Score: 0.006
  38. Transcranial Doppler assessment of cerebral perfusion reserve in patients with carotid occlusive disease and no evidence of cerebral infarction. Neurology. 1993 Feb; 43(2):353-7.
    View in: PubMed
    Score: 0.006
  39. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012 Oct; 43(10):2682-8.
    View in: PubMed
    Score: 0.006
  40. Utilization of CT perfusion patient selection for mechanical thrombectomy irrespective of time: a comparison of functional outcomes and complications. J Neurointerv Surg. 2013 Nov; 5(6):518-22.
    View in: PubMed
    Score: 0.006
  41. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol. 1992 Jul; 49(7):747-52.
    View in: PubMed
    Score: 0.005
  42. Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke. 2012 May; 43(5):1230-3.
    View in: PubMed
    Score: 0.005
  43. Etiology of motor or sensory stroke: a prospective study of the predictive value of clinical and radiological features. Ann Neurol. 1991 Oct; 30(4):519-25.
    View in: PubMed
    Score: 0.005
  44. CT perfusion-guided patient selection for endovascular treatment of acute ischemic stroke is safe and effective. J Neurointerv Surg. 2012 Jul; 4(4):261-5.
    View in: PubMed
    Score: 0.005
  45. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011 Jun; 69(6):963-74.
    View in: PubMed
    Score: 0.005
  46. Treatment of intractable arterial hemorrhage during stereotactic brain biopsy with thrombin. Report of three patients. J Neurosurg. 1991 Feb; 74(2):301-3.
    View in: PubMed
    Score: 0.005
  47. Mechanism of stroke in patients taking aspirin. Neurology. 1990 Nov; 40(11):1682-5.
    View in: PubMed
    Score: 0.005
  48. Ipsilateral leg weakness associated with carotid stenosis. Stroke. 1990 Sep; 21(9):1362-4.
    View in: PubMed
    Score: 0.005
  49. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke. 2010 Aug; 41(8):1636-40.
    View in: PubMed
    Score: 0.005
  50. Resolution of psychotic depression after right temporoparietal infarction. J Nerv Ment Dis. 1990 Jul; 178(7):458-9.
    View in: PubMed
    Score: 0.005
  51. The accuracy of bedside neurological diagnoses. Ann Neurol. 1990 Jul; 28(1):78-85.
    View in: PubMed
    Score: 0.005
  52. Intracranial hypertension associated with unruptured cerebral arteriovenous malformations. Ann Neurol. 1990 May; 27(5):474-9.
    View in: PubMed
    Score: 0.005
  53. HIV-associated CIDP. Muscle Nerve. 1989 Aug; 12(8):695-6.
    View in: PubMed
    Score: 0.004
  54. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 2009 Jun 09; 72(23):2014-9.
    View in: PubMed
    Score: 0.004
  55. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009 Feb; 40(2):505-9.
    View in: PubMed
    Score: 0.004
  56. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008 Apr 22; 70(17):1518-24.
    View in: PubMed
    Score: 0.004
  57. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007 Nov 27; 69(22):2063-8.
    View in: PubMed
    Score: 0.004
  58. Echocardiography in patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis. 2007 Sep-Oct; 16(5):216-9.
    View in: PubMed
    Score: 0.004
  59. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2007; 24(2-3):283-8.
    View in: PubMed
    Score: 0.004
  60. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke. 2007 Jul; 38(7):2055-62.
    View in: PubMed
    Score: 0.004
  61. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007 Jun 12; 115(23):2969-75.
    View in: PubMed
    Score: 0.004
  62. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology. 2007 Jun 12; 68(24):2099-106.
    View in: PubMed
    Score: 0.004
  63. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 2006 Oct 10; 67(7):1275-8.
    View in: PubMed
    Score: 0.004
  64. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology. 2006 May 09; 66(9):1344-9.
    View in: PubMed
    Score: 0.004
  65. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006 Jan 31; 113(4):555-63.
    View in: PubMed
    Score: 0.003
  66. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003 Sep 09; 108(10):1278-90.
    View in: PubMed
    Score: 0.003
  67. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke. 2002 Dec; 33(12):2762-8.
    View in: PubMed
    Score: 0.003
  68. Right atrial spontaneous contrast: echocardiographic and clinical features. Int J Card Imaging. 1994 Sep; 10(3):227-32.
    View in: PubMed
    Score: 0.002
  69. Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. Am J Cardiol. 1991 Dec 01; 68(15):1498-502.
    View in: PubMed
    Score: 0.001
  70. Sclerosing vasculopathy of the central nervous system in nonelderly demented patients. Arch Neurol. 1991 Jun; 48(6):631-6.
    View in: PubMed
    Score: 0.001
  71. Stroke in patients with fusiform vertebrobasilar aneurysms. Neurology. 1989 Jan; 39(1):16-21.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.